On October 26th, the second session of online forum on clinical application advances of Cryosurgical System was held as scheduled.
Prof. Xiong Bin
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Old friend, new spring
Hygea Medical and I are old friends. It has developed into an outstanding representative in the field of oncology intervention in China. The Cryosurgical System has excellent clinical experience and outstanding ablation effect, especially in analgesia, immunity and deep cryogenic temperature. In the systematic pattern of tumor treatment, local precise combined cryoablation and hyperthermia ablation has become the new cornerstone of multi-cancer comprehensive treatment, and the "new spring" of cryoablation has thus started! The multi-dimensional innovative “AI Epic” series products will surely play a more important role in the field of oncology therapy.
Prof. Niu Lizhi
Fuda Cancer Hospital, Jinan University
Stronger tumor killing effect
Cryoablation has a long history already, with the treatment of breast cancer reported in the middle of the 19th century. At the end of the 20th century, cryoablation was empowered by ultrasound technology and was approved for the treatment of complex adjacent prostate cancer, thanks to the unique mechanism of preserving the fibrous architecture of organ tissues, piercing tumor cells with ice crystals, forming microthrombosis, initiating apoptosis and stimulating immune effects. For the ablation treatment of lung tumors, the Occident countries, represented by France, have made cryoablation the first choice; in the field of breast cancer, Japanese experts are recommending to the world the non-inferior efficacy and appearance preservation of cryoablation treatment.
The shaft diameter of ablation probe provided by foreign manufacturer in the field of liquid nitrogen technology is currently 3.4mm, while Prof. Liu Jing and Hygea Medical achieved 2mm long time ago, and the new model of this year reached to 1.7mm. Hygea is the first manufacturer which let Chinese doctors take the lead in using the lowest temperature (-196℃) for medical treatment. The lower temperature brings stronger tumor cell killing ability, and the 80℃ high temperature is much higher than the imported products. The thermal stress of nearly 300℃ temperature difference ensures a complete ablation. Fuda Cancer Hospital has carried out the treatment of lung cancer, liver cancer, breast cancer and osteosarcoma with the application of Cryosurgical System and has achieved very good treatment effect. We hope that with the efforts of our colleagues in the industry, we can promote our national brand for the benefit of more cancer patients.
Huang Wenming
Deputy General Manager, Hygea Medical Technology Co., Ltd.
Never forget the original intention and keep moving forward!
We would like to thank all the experts for taking their valuable time to participate in the second session of the online academic event. Prof. Niu Lizhi is one of the most experienced experts in cryotherapy for tumors in China and the world, and he has accumulated a wealth of cases and experience in the clinical application of the Cryosurgical System. Prof. Xiong Bin, Prof. Lu Wei and Prof. Luo Baoping have also achieved very good clinical effect in the application of Cryosurgical System in the treatment of tumor patients. Hygea Medical attaches great importance to promote academic exchanges in the field of tumor intervention and expects to cooperate more extensively and deeply with all the experts to bring benefits to the patients and make its contribution to the medical and health services in China. Hygea Medical will not forget its original intention and keep moving forward!
Prof. Lu Wei
Zhongnan Hospital of Wuhan University
Significant clinical benefit and cost advantage
The 80°C high-temperature heating provided by the Cryosurgical System is sufficient to cause coagulative necrosis of the interstitium and organelles within the tumor cells, while providing additional hemostasis and pain relief. And, as other specialists are most likely to mention, an extremely significant improvement in patient experience, with the strong demand for pain relief usually being met immediately after the Cryosurgical System procedure. In addition, the cost of the working medium has significantly advantage, at only 3% of the cost of argon helium gas per procedure. The norms, guidelines and expert consensus in the field of lung cancer, lung nodules and liver cancer also provide great support and guidance to our clinical practice. We hope to have more cases and experiences to share with you in the future. Click for Cryoablation for Lung Cancer and Cryoablation for Liver Cancer
Prof. Luo Baoping
Hubei Provincial Hospital of Traditional Chinese Medicine
Green therapy, safe and effective
As an in-depth participant in the subject of stage III and IV lung cancer and the National Major Research and Development Program, I have deep impression on Cryosurgical System. Compared with MWA and RFA, Cryosurgical System has a significantly lower probability of cavities in the lung after surgery, faster absorption of necrotic tissue, clear ablation boundaries and it can help the physician better control the ablation boundaries.
As Prof. Niu mentioned that the precise preoperative planning of different organs, different locations, different forms, and different adjacent is extremely important for the smooth and effective procedure. And the systemic treatment constituted with different traditional means allows the patients to get good benefits. It is worth mentioning that, among similar technologies, the Cryosurgical System has a broader indication and can be used for a wide range of solid tumors in non-cavity organs.
Wang Xiaoming
Hygea Medical Technology Co., Ltd.
Multiple upgrades
The "AI Epic" series of Cryosurgical System is a new series of products launched by Hygea Medical accumulating 5 years of clinical feedback and combining the latest scientific research results to meet the actual needs of different levels of medical institutions, different solid tumors treatment and different departments in China. With a new UI design, user-friendly system, and 16 safety protections as standard, the multiple updates focus on ease of use, comprehensive needs, and improvement of the operator's actual experience. The system with different shaft diameters, treatment areas and lengths, can better satisfy the clinical needs.
Discussion session and consensus:
Technology popularization:
The application of "fishing technology" in lung ablation can reduce the occurrence of complications.
The precise control of ablation boundary in different organs is the key to reduce the "recurrence rate".
The ablation zone is larger and the temperature difference is nearly 300℃. Stronger killing effect by thermal stress.
Preferred scenario:
GGO, 5 years without recurrence. Profited by precise preoperative planning and technical proficiency. The outcome is significantly better than thermal ablation technology.
The postoperative recurrence and the second huge trauma is not tolerated by many patients. Cryosurgical System can be an important core option for comprehensive treatment.
For patient with multiple lesions and poor lung function, who is inoperable, the ablation treatment is the key therapy. The interventional experts are usually familiar with the ablation therapy. The promotion of the technology depends on extensive multidisciplinary cooperation, such as combined immunotherapy and personalized treatment.
Technical advantages of Cryosurgical System:
Stronger thermal stress tumor killing capacity.
Hyperthermia treatment with prevention of needle tract bleeding effect.
Pain relief.
Ablation probe with different specifications can better satisfy the clinical needs.
Hygea Medical Technology Co., Ltd.
Hygea Medical Technology Co., Ltd.
EN 
